GIVLAARI

Serial Number 87784738
Registration 5985026
700

Registration Progress

Application Filed
Feb 5, 2018
Under Examination
Jun 26, 2018
Approved for Publication
May 1, 2018
Published for Opposition
May 1, 2018
Registered
Feb 11, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-02-11)
Due: Feb 11, 2026 217 days

Basic Information

Serial Number
87784738
Registration Number
5985026
Deadline
February 11, 2026
Description
5 Year - Section 8 and 15 Renewal
Filing Date
February 5, 2018
Registration Date
February 11, 2020
Published for Opposition
May 1, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 11, 2020
Registration
Registered
Classes
005

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street
Cambridge, MA 02142

Quick Actions

Search by Rights Holder Search by Attorney Search by Status Code 700

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Timothy H. Hiebert

USPTO Deadlines

Next Deadline
217 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-02-11)
Due Date
February 11, 2026
Grace Period Ends
August 11, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description
Feb 11, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 11, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER
Jan 4, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 3, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 17, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Dec 17, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 11, 2019 IUAF S USE AMENDMENT FILED
Dec 11, 2019 EISU I TEAS STATEMENT OF USE RECEIVED
Jun 1, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 30, 2019 EX2G S SOU EXTENSION 2 GRANTED
May 30, 2019 EXT2 S SOU EXTENSION 2 FILED
May 30, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 8, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 6, 2018 EX1G S SOU EXTENSION 1 GRANTED
Nov 6, 2018 EXT1 S SOU EXTENSION 1 FILED
Nov 6, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 26, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 1, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 1, 2018 PUBO A PUBLISHED FOR OPPOSITION
Apr 11, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 29, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 29, 2018 DOCK D ASSIGNED TO EXAMINER
Feb 13, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 8, 2018 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of porphyria
First Use Anywhere: Dec 10, 2019
First Use in Commerce: Dec 10, 2019

Additional Information

Translation
The wording "GIVLAARI" has no meaning in a foreign language.

Classification

International Classes
005